These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 9458745

  • 1. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E, Ishida H, Kato S, Tsuura Y, Fujimoto S, Ishida-Takahashi A, Horie M, Tsuda K, Seino Y.
    Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
    [Abstract] [Full Text] [Related]

  • 2. The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2.
    Mukai E, Ishida H, Horie M, Noma A, Seino Y, Takano M.
    Biochem Biophys Res Commun; 1998 Oct 20; 251(2):477-81. PubMed ID: 9792799
    [Abstract] [Full Text] [Related]

  • 3. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
    Chen M, Dong Y, Simard JM.
    J Neurosci; 2003 Sep 17; 23(24):8568-77. PubMed ID: 13679426
    [Abstract] [Full Text] [Related]

  • 4. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM, Tucker SJ, Seino S, Ashcroft FM.
    Diabetes; 1998 Sep 17; 47(9):1412-8. PubMed ID: 9726229
    [Abstract] [Full Text] [Related]

  • 5. Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.
    Ishida-Takahashi A, Horie M, Tsuura Y, Ishida H, Ai T, Sasayama S.
    Br J Pharmacol; 1996 Apr 17; 117(8):1749-55. PubMed ID: 8732286
    [Abstract] [Full Text] [Related]

  • 6. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y, Tinker A, Clapp LH.
    Br J Pharmacol; 2003 May 17; 139(1):122-8. PubMed ID: 12746230
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies.
    Nakamura A, Kawahito S, Kawano T, Nazari H, Takahashi A, Kitahata H, Nakaya Y, Oshita S.
    Anesthesiology; 2007 Mar 17; 106(3):515-22. PubMed ID: 17325510
    [Abstract] [Full Text] [Related]

  • 8. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H, Sunagawa M, Seki T, Sperelakis N.
    Pflugers Arch; 1999 Feb 17; 437(3):400-8. PubMed ID: 9914396
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG, Kinsella JM, Campbell CM, Ashford ML.
    Br J Pharmacol; 2000 Jun 17; 130(4):857-66. PubMed ID: 10864893
    [Abstract] [Full Text] [Related]

  • 10. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
    Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J.
    Circ Res; 1998 Nov 30; 83(11):1132-43. PubMed ID: 9831708
    [Abstract] [Full Text] [Related]

  • 11. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
    Fujita H, Ogura T, Tamagawa M, Uemura H, Sato T, Ishida A, Imamaki M, Kimura F, Miyazaki M, Nakaya H.
    Br J Pharmacol; 2006 Nov 30; 149(5):573-80. PubMed ID: 17001304
    [Abstract] [Full Text] [Related]

  • 12. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K, Komine J, Matsuo M, Seino S, Amachi T.
    Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1268-72. PubMed ID: 9990013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
    Insuk SO, Chae MR, Choi JW, Yang DK, Sim JH, Lee SW.
    Int J Impot Res; 2003 Aug 16; 15(4):258-66. PubMed ID: 12934053
    [Abstract] [Full Text] [Related]

  • 16. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y.
    J Pharmacol Exp Ther; 2003 Mar 16; 304(3):1025-32. PubMed ID: 12604678
    [Abstract] [Full Text] [Related]

  • 17. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D, Winkler M, Kühner P, Russ U, Quast U.
    Diabetologia; 2006 Sep 16; 49(9):2039-48. PubMed ID: 16865362
    [Abstract] [Full Text] [Related]

  • 18. Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics.
    Horie M, Hayashi S, Yuzuki Y, Sasayama S.
    Cardiovasc Res; 1992 Nov 16; 26(11):1087-94. PubMed ID: 1291086
    [Abstract] [Full Text] [Related]

  • 19. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W, Leech CA, Ferrer J, Habener JF.
    Endocrinology; 2001 Jan 16; 142(1):129-38. PubMed ID: 11145575
    [Abstract] [Full Text] [Related]

  • 20. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J, Nagashima K, Tanaka J, Miki T, Miyazaki M, Gonoi T, Mitsuhashi N, Nakajima N, Iwanaga T, Yano H, Seino S.
    Diabetes; 1999 Oct 16; 48(10):2001-6. PubMed ID: 10512365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.